About Enrico Cagliero, MD
Dr. Cagliero completed his internship and residency at the University of California, San Diego and his fellowship in Endocrinology at Massachusetts General Hospital. He joined the Diabetes Center at Massachusetts General Hospital in 1995, and is currently an Associate Professor of Medicine at Harvard Medical School. He is now dividing his time between a busy clinical practice, his clinical research efforts and teaching activities.
Clinical Interests:
- Diabetes management
- Endocrinology
- Lipid disorders
Treats:
- Adult
Languages:
- Italian
Locations
Mass General Endocrinology: Diabetes Clinical Center
50 Staniford St.
Suite 340
Boston, MA 02114
Phone: 617-726-8722
Medical Education
- MD, University of Torino
- Residency, San Diego Medical Center
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Endocrinology, Diabetes & Metabolism, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid NY
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Cagliero initiated a clinical program for islet cell transplantation at Harvard Medical School, developed an electronic diabetes management application for primary care physicians taking care of type 2 diabetic patients, and worked on several projects focused on improving care for diabetic patients with depression and other mental health issues. Moreover, Dr. Cagliero has been taking part in several seminal multicenter diabetes studies including the Diabetes Prevention Program (DPP), the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC), the Look AHEAD trial, and the Preventing Early Renal Loss in Diabetes (PERL) Study.